10 studies found for:    Open Studies | "Coxsackievirus Infections"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Ipilimumab
2 Recruiting Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam
Condition: Hand Foot and Mouth Disease
Intervention:
3 Recruiting Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth Disease
Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid;   Drug: Ribavirin
4 Recruiting Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Magnesium Sulphate;   Drug: Sterile water
5 Unknown  A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Drug: Xiyanping Injection;   Drug: Xiyanping Injection with western medicine
6 Unknown  A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Other: Reduning Injection;   Other: Reduning Injection plus western therapy
7 Unknown  A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Herbal concentrate-granules plus western therapy;   Drug: Reduning Injection plus western therapy;   Drug: Western therapy
8 Recruiting Efficacy and Safety of Intratumoral CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks
Condition: Melanoma
Intervention: Biological: Coxsackievirus A21
9 Recruiting Safety and Clinical Activity of CAVATAK™ Alone or With Low Dose Mitomycin C in Non-muscle Invasive Bladder Cancer
Condition: Non-muscle Invasive Bladder Cancer
Interventions: Biological: CAVATAK;   Drug: Mitomycin C
10 Recruiting Systemic Treatment of Resistant Metastatic Disease
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21

Indicates status has not been verified in more than two years